Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 11.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 349,254 shares of the company's stock after purchasing an additional 36,422 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.54% of Bain Capital Specialty Finance worth $5,798,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. CFO4Life Group LLC raised its position in Bain Capital Specialty Finance by 2.5% during the fourth quarter. CFO4Life Group LLC now owns 31,499 shares of the company's stock valued at $552,000 after purchasing an additional 769 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Bain Capital Specialty Finance by 1.5% in the first quarter. Janney Montgomery Scott LLC now owns 77,209 shares of the company's stock worth $1,282,000 after buying an additional 1,107 shares during the period. Lazard Asset Management LLC raised its holdings in shares of Bain Capital Specialty Finance by 14.5% in the fourth quarter. Lazard Asset Management LLC now owns 9,361 shares of the company's stock worth $164,000 after buying an additional 1,189 shares during the period. Comerica Bank raised its holdings in shares of Bain Capital Specialty Finance by 8.2% in the fourth quarter. Comerica Bank now owns 17,029 shares of the company's stock worth $298,000 after buying an additional 1,292 shares during the period. Finally, Mascoma Wealth Management LLC purchased a new stake in shares of Bain Capital Specialty Finance in the fourth quarter worth approximately $29,000.
Analyst Ratings Changes
BCSF has been the topic of several recent analyst reports. Wells Fargo & Company reduced their price target on Bain Capital Specialty Finance from $19.00 to $16.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. Keefe, Bruyette & Woods reduced their price target on Bain Capital Specialty Finance from $18.00 to $17.00 and set a "market perform" rating on the stock in a report on Tuesday, April 8th.
View Our Latest Research Report on BCSF
Bain Capital Specialty Finance Trading Up 0.7%
Shares of NYSE BCSF traded up $0.10 during midday trading on Friday, hitting $15.25. The company's stock had a trading volume of 165,382 shares, compared to its average volume of 244,471. Bain Capital Specialty Finance, Inc. has a 12-month low of $13.20 and a 12-month high of $19.21. The firm has a market cap of $989.27 million, a P/E ratio of 8.76 and a beta of 0.78. The business's 50 day moving average is $15.32 and its two-hundred day moving average is $16.42. The company has a current ratio of 3.69, a quick ratio of 3.69 and a debt-to-equity ratio of 1.27.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. Bain Capital Specialty Finance had a return on equity of 11.62% and a net margin of 39.60%. The company had revenue of $52.84 million for the quarter, compared to analysts' expectations of $71.00 million. As a group, equities research analysts expect that Bain Capital Specialty Finance, Inc. will post 2.06 EPS for the current year.
Bain Capital Specialty Finance Dividend Announcement
The company also recently disclosed a dividend, which was paid on Monday, June 30th. Investors of record on Tuesday, June 17th were paid a $0.03 dividend. The ex-dividend date was Monday, June 16th. This represents a yield of 11.66%. Bain Capital Specialty Finance's dividend payout ratio (DPR) is currently 96.55%.
Bain Capital Specialty Finance Company Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Further Reading

Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.